Facilities & Capacity
Novo Nordisk ploughs another $2bn+ into GLP-1 production
Facilities & CapacityNovo Nordisk ploughs another $2bn+ into GLP-1 productionNovo Nordisk ploughs another $2bn+ into GLP-1 production
Having pledged $6 billion in Denmark, Novo Nordisk will now increase capacity at its Chartres site to support obesity and diabetes products.